While we established a role for NFE2L3 in the promotion of inflammation-induced colorectal cancer, it is unclear whether the observed phenotype is due to loss of NFE2L3 within the colonic cells and/or the immune cells or both. Here, NFE2L3 is linked to colorectal cancer.